Viral Hepatitis in Pregnancy ACOG Clinical Practice Guideline No. 6
PURPOSE:The purpose of this document is to describe the specific types of viral hepatitis, their implications during pregnancy, the risk of perinatal transmission, and issues related to both treatment and prevention of infection.TARGET POPULATION:Pregnant or postpartum women and individuals who scre...
Saved in:
| Published in | Obstetrics and gynecology (New York. 1953) Vol. 142; no. 3; pp. 745 - 759 |
|---|---|
| Format | Journal Article |
| Language | English |
| Published |
United States
Lippincott Williams & Wilkins
01.09.2023
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0029-7844 1873-233X 1873-233X |
| DOI | 10.1097/AOG.0000000000005300 |
Cover
| Abstract | PURPOSE:The purpose of this document is to describe the specific types of viral hepatitis, their implications during pregnancy, the risk of perinatal transmission, and issues related to both treatment and prevention of infection.TARGET POPULATION:Pregnant or postpartum women and individuals who screen positive for viral hepatitis infection. The onset of these conditions may have predated the perinatal period or may have occurred for the first time in pregnancy or the first year postpartum.METHODS:This guideline was developed using an a priori protocol in conjunction with a writing team consisting of one specialist in obstetrics and gynecology appointed by the ACOG Committee on Clinical Practice Guidelines-Obstetrics and one external subject matter expert. ACOG medical librarians completed a comprehensive literature search for primary literature within Cochrane Library, Cochrane Collaboration Registry of Controlled Trials, EMBASE, PubMed, and MEDLINE. Studies that moved forward to the full-text screening stage were assessed by two authors from the writing team based on standardized inclusion and exclusion criteria. Included studies underwent quality assessment, and a modified GRADE (Grading of Recommendations Assessment, Development, and Evaluation) evidence-to-decision framework was applied to interpret and translate the evidence into recommendation statements.RECOMMENDATIONS:This Clinical Practice Guideline includes recommendations on hepatitis B virus and hepatitis C virus screening in pregnancy; prepregnancy, antepartum, intrapartum, and postpartum management for patients with hepatitis B virus infection or hepatitis C virus infection; management of accidental and occupational exposure to hepatitis B virus or hepatitis C virus in pregnant health care workers; and hepatitis A virus and hepatitis B virus vaccination in pregnancy. Recommendations are classified by strength and evidence quality. Ungraded Good Practice Points are included to provide guidance when a formal recommendation could not be made because of inadequate or nonexistent evidence. |
|---|---|
| AbstractList | The purpose of this document is to describe the specific types of viral hepatitis, their implications during pregnancy, the risk of perinatal transmission, and issues related to both treatment and prevention of infection.PURPOSEThe purpose of this document is to describe the specific types of viral hepatitis, their implications during pregnancy, the risk of perinatal transmission, and issues related to both treatment and prevention of infection.Pregnant or postpartum women and individuals who screen positive for viral hepatitis infection. The onset of these conditions may have predated the perinatal period or may have occurred for the first time in pregnancy or the first year postpartum.TARGET POPULATIONPregnant or postpartum women and individuals who screen positive for viral hepatitis infection. The onset of these conditions may have predated the perinatal period or may have occurred for the first time in pregnancy or the first year postpartum.This guideline was developed using an a priori protocol in conjunction with a writing team consisting of one specialist in obstetrics and gynecology appointed by the ACOG Committee on Clinical Practice Guidelines-Obstetrics and one external subject matter expert. ACOG medical librarians completed a comprehensive literature search for primary literature within Cochrane Library, Cochrane Collaboration Registry of Controlled Trials, EMBASE, PubMed, and MEDLINE. Studies that moved forward to the full-text screening stage were assessed by two authors from the writing team based on standardized inclusion and exclusion criteria. Included studies underwent quality assessment, and a modified GRADE (Grading of Recommendations Assessment, Development, and Evaluation) evidence-to-decision framework was applied to interpret and translate the evidence into recommendation statements.METHODSThis guideline was developed using an a priori protocol in conjunction with a writing team consisting of one specialist in obstetrics and gynecology appointed by the ACOG Committee on Clinical Practice Guidelines-Obstetrics and one external subject matter expert. ACOG medical librarians completed a comprehensive literature search for primary literature within Cochrane Library, Cochrane Collaboration Registry of Controlled Trials, EMBASE, PubMed, and MEDLINE. Studies that moved forward to the full-text screening stage were assessed by two authors from the writing team based on standardized inclusion and exclusion criteria. Included studies underwent quality assessment, and a modified GRADE (Grading of Recommendations Assessment, Development, and Evaluation) evidence-to-decision framework was applied to interpret and translate the evidence into recommendation statements.This Clinical Practice Guideline includes recommendations on hepatitis B virus and hepatitis C virus screening in pregnancy; prepregnancy, antepartum, intrapartum, and postpartum management for patients with hepatitis B virus infection or hepatitis C virus infection; management of accidental and occupational exposure to hepatitis B virus or hepatitis C virus in pregnant health care workers; and hepatitis A virus and hepatitis B virus vaccination in pregnancy. Recommendations are classified by strength and evidence quality. Ungraded Good Practice Points are included to provide guidance when a formal recommendation could not be made because of inadequate or nonexistent evidence.RECOMMENDATIONSThis Clinical Practice Guideline includes recommendations on hepatitis B virus and hepatitis C virus screening in pregnancy; prepregnancy, antepartum, intrapartum, and postpartum management for patients with hepatitis B virus infection or hepatitis C virus infection; management of accidental and occupational exposure to hepatitis B virus or hepatitis C virus in pregnant health care workers; and hepatitis A virus and hepatitis B virus vaccination in pregnancy. Recommendations are classified by strength and evidence quality. Ungraded Good Practice Points are included to provide guidance when a formal recommendation could not be made because of inadequate or nonexistent evidence. The purpose of this document is to describe the specific types of viral hepatitis, their implications during pregnancy, the risk of perinatal transmission, and issues related to both treatment and prevention of infection. Pregnant or postpartum women and individuals who screen positive for viral hepatitis infection. The onset of these conditions may have predated the perinatal period or may have occurred for the first time in pregnancy or the first year postpartum. This guideline was developed using an a priori protocol in conjunction with a writing team consisting of one specialist in obstetrics and gynecology appointed by the ACOG Committee on Clinical Practice Guidelines-Obstetrics and one external subject matter expert. ACOG medical librarians completed a comprehensive literature search for primary literature within Cochrane Library, Cochrane Collaboration Registry of Controlled Trials, EMBASE, PubMed, and MEDLINE. Studies that moved forward to the full-text screening stage were assessed by two authors from the writing team based on standardized inclusion and exclusion criteria. Included studies underwent quality assessment, and a modified GRADE (Grading of Recommendations Assessment, Development, and Evaluation) evidence-to-decision framework was applied to interpret and translate the evidence into recommendation statements. This Clinical Practice Guideline includes recommendations on hepatitis B virus and hepatitis C virus screening in pregnancy; prepregnancy, antepartum, intrapartum, and postpartum management for patients with hepatitis B virus infection or hepatitis C virus infection; management of accidental and occupational exposure to hepatitis B virus or hepatitis C virus in pregnant health care workers; and hepatitis A virus and hepatitis B virus vaccination in pregnancy. Recommendations are classified by strength and evidence quality. Ungraded Good Practice Points are included to provide guidance when a formal recommendation could not be made because of inadequate or nonexistent evidence. PURPOSE:The purpose of this document is to describe the specific types of viral hepatitis, their implications during pregnancy, the risk of perinatal transmission, and issues related to both treatment and prevention of infection.TARGET POPULATION:Pregnant or postpartum women and individuals who screen positive for viral hepatitis infection. The onset of these conditions may have predated the perinatal period or may have occurred for the first time in pregnancy or the first year postpartum.METHODS:This guideline was developed using an a priori protocol in conjunction with a writing team consisting of one specialist in obstetrics and gynecology appointed by the ACOG Committee on Clinical Practice Guidelines-Obstetrics and one external subject matter expert. ACOG medical librarians completed a comprehensive literature search for primary literature within Cochrane Library, Cochrane Collaboration Registry of Controlled Trials, EMBASE, PubMed, and MEDLINE. Studies that moved forward to the full-text screening stage were assessed by two authors from the writing team based on standardized inclusion and exclusion criteria. Included studies underwent quality assessment, and a modified GRADE (Grading of Recommendations Assessment, Development, and Evaluation) evidence-to-decision framework was applied to interpret and translate the evidence into recommendation statements.RECOMMENDATIONS:This Clinical Practice Guideline includes recommendations on hepatitis B virus and hepatitis C virus screening in pregnancy; prepregnancy, antepartum, intrapartum, and postpartum management for patients with hepatitis B virus infection or hepatitis C virus infection; management of accidental and occupational exposure to hepatitis B virus or hepatitis C virus in pregnant health care workers; and hepatitis A virus and hepatitis B virus vaccination in pregnancy. Recommendations are classified by strength and evidence quality. Ungraded Good Practice Points are included to provide guidance when a formal recommendation could not be made because of inadequate or nonexistent evidence. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37590986$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkD1PwzAQQC1URD_gH1SoI0vKOXZim62qoEWqVAZAbJbjXGggTYqdqOq_J6gFoQ5wyy3vnXSvTzplVSIhQwpjCkpcT5azMfyaiAGckB6VggUhYy8d0gMIVSAk513S9_6thWis2BnpMhEpUDLukeFz7kwxmuPG1Hmd-1Fejh4cvpamtLtzcpqZwuPFYQ_I093t43QeLJaz--lkEVgWxRDIFAEpzSwDkcYSKYJQaSZsImzKBQAmnGYQc5HQVFkhKZcKkohCFEbKAhuQq_3djas-GvS1XufeYlGYEqvG61BGTHFGY9ailwe0SdaY6o3L18bt9PdHLcD3gHWV9w6zH4SC_gqn23D6OFyr3RxpNq_bJFVZO5MX_8lyL2-rokbn34tmi06v0BT16m_1E3pTf3k |
| CitedBy_id | crossref_primary_10_1016_j_ajog_2023_12_023 crossref_primary_10_1097_01_PGO_0001093336_50588_79 crossref_primary_10_1097_AOG_0000000000005499 crossref_primary_10_1097_AOG_0000000000005555 crossref_primary_10_1097_AOG_0000000000005703 crossref_primary_10_1093_ofid_ofae632 crossref_primary_10_3390_pathogens13080651 crossref_primary_10_1093_jpids_piae066 crossref_primary_10_1016_j_jogn_2024_09_008 crossref_primary_10_1097_INF_0000000000004251 crossref_primary_10_2337_dc25_S015 crossref_primary_10_1016_j_eclinm_2024_103038 crossref_primary_10_1016_j_eclinm_2024_103039 crossref_primary_10_1128_cmr_00073_23 crossref_primary_10_1089_jwh_2023_1114 crossref_primary_10_1016_j_xagr_2024_100317 crossref_primary_10_1016_j_eclinm_2024_102727 crossref_primary_10_3389_fmicb_2025_1553129 crossref_primary_10_3390_v16020314 |
| Cites_doi | 10.1016/j.ajog.2015.09.100 10.1111/jvh.12430 10.1002/hep.1840150204 10.1186/1471-2458-11-502 10.15585/mmwr.rr7004a1 10.1093/cid/ciw092 10.15585/mmwr.rr6902a1 10.1097/AOG.0000000000004519 10.1002/14651858.CD005546.pub2 10.1016/j.jhep.2005.06.002 10.1111/jvh.12670 10.1155/2014/350179 10.1097/00006454-199904000-00020 10.1001/jama.2020.1123 10.1186/1743-422X-9-185 10.1186/1743-422X-5-100 10.1136/bmj.39489.470347 10.1001/jama.2019.9365 10.1007/s11904-022-00643-9 10.1080/14787210.2022.2125868 10.1111/hepr.13072 10.1016/j.jclinepi.2010.04.026 10.1016/j.ajog.2022.02.042 10.1053/j.gastro.2006.01.007 10.1017/S0950268816000418 10.1111/apt.12726 10.1002/hep.28156 10.15585/mmwr.rr6905a1 10.1016/j.jclinepi.2014.12.011 10.1016/j.clinre.2016.07.004 10.1097/AOG.0000000000001405 10.1097/AOG.0000000000004652 10.1097/MCG.0000000000000115 10.1001/jamahealthforum.2021.3470 10.1001/archpediatrics.2011.72 10.1016/j.ajog.2021.06.008 10.1097/INF.0000000000001516 10.15585/mmwr.rr6701a1 10.1371/journal.pone.0055303 10.1097/MD.0000000000004777 10.1007/s00404-010-1588-9 10.1001/jama.261.9.1321 10.1111/jvh.12379 10.1002/14651858.CD008545.pub2 10.1086/381671 10.15585/mmwr.rr7201a1 10.15585/mmwr.rr6906a1 10.1097/00005792-199201000-00002 10.1093/cid/ciu798 10.7326/M17-1106 10.3138/canlivj.2018-0008 10.1111/jvh.12730 10.1046/j.1440-1746.2000.02006.x 10.1016/j.jhep.2022.05.016 10.1016/j.jogc.2016.11.001 10.1002/rmv.1929 10.1542/peds.106.4.e54 10.1016/j.jhep.2013.11.008 10.1016/j.jcv.2015.10.011 10.1017/s0950268899003003 10.7326/0003-4819-158-2-201301150-00575 10.1093/cid/ciab405 10.1542/peds.2014-3213 10.1016/j.ajog.2021.09.002 10.15585/mmwr.mm7113a1 10.1136/bmj.39489.470347.AD 10.1017/S0950268899003003 10.1001/jama.1989.03420090085036 |
| ContentType | Journal Article |
| Copyright | 2023 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved. Copyright © 2023 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved. |
| Copyright_xml | – notice: 2023 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved. – notice: Copyright © 2023 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1097/AOG.0000000000005300 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1873-233X |
| EndPage | 759 |
| ExternalDocumentID | 37590986 10_1097_AOG_0000000000005300 ONG-23-1163 |
| Genre | other Journal Article Practice Guideline |
| GroupedDBID | --- --K .3C .55 .GJ .XZ .Z2 01R 0R~ 123 1B1 1CY 1J1 1~5 29N 2CO 354 3O- 4.4 40H 4G. 4Q1 4Q2 4Q3 53G 5RE 5VS 7-5 77Y 7O~ 85S AAAAV AAAXR AAEDT AAGIX AAHPQ AAIQE AAJCS AALRI AAMOA AAMTA AAQFI AAQKA AAQQT AAQXK AARTV AASCR AASOK AASXQ AAUEB AAWTL AAXQO AAXUO AAYWO ABASU ABBUW ABDIG ABDPE ABJNI ABMAC ABPXF ABVCZ ABWVN ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACDOF ACEWG ACGFO ACGFS ACILI ACIUM ACLDA ACOAL ACRPL ACVFH ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADCNI ADFPA ADGGA ADHPY ADMUD ADNKB ADNMO AE3 AEBDS AEETU AENEX AEUPX AFBFQ AFDTB AFEXH AFFNX AFMBP AFNMH AFPUW AFSOK AFTJW AFUWQ AGINI AGNAY AGQPQ AHOMT AHQNM AHQVU AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKRWK AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BAWUL BOYCO BQLVK BS7 BYPQX C45 CS3 DIWNM DU5 DUNZO E.X EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FD6 FDB FEDTE FGOYB FL- FW0 GNXGY GQDEL H0~ HLJTE HVGLF HZ~ IHE IKREB IKYAY IN~ IPNFZ JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI L-C L7B M18 M41 MZP N4W N9A NEJ NQ- N~7 N~B N~M O9- OAG OAH OBH OCUKA ODA ODMTH OHH OHT OHYEH OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWX OWY OWZ OXXIT P-K P2P R2- R58 RIG RLZ ROL RPZ S4R S4S SSZ TEORI TSPGW TWZ UHB V2I VVN W3M WH7 WOQ WOW X3V X3W X7M XPP XXN XYM YQJ ZB8 ZGI ZXP ZZMQN ~S- AAYXX ADKSD ADSXY CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c3560-8de0e11fc307d68e1e079df7cb7cd4700eb41f0647b1d9c7814890b5105259c03 |
| ISSN | 0029-7844 1873-233X |
| IngestDate | Mon Sep 08 14:41:49 EDT 2025 Mon Jul 21 05:55:16 EDT 2025 Wed Oct 01 06:35:03 EDT 2025 Thu Apr 24 23:05:47 EDT 2025 Tue Jul 22 08:40:29 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| License | Copyright © 2023 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c3560-8de0e11fc307d68e1e079df7cb7cd4700eb41f0647b1d9c7814890b5105259c03 |
| Notes | This information is designed as an educational resource to aid clinicians in providing obstetric and gynecologic care, and use of this information is voluntary. This information should not be considered as inclusive of all proper treatments or methods of care or as a statement of the standard of care. It is not intended to substitute for the independent professional judgment of the treating clinician. Variations in practice may be warranted when, in the reasonable judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology. The American College of Obstetricians and Gynecologists (ACOG) reviews its publications regularly; however, its publications may not reflect the most recent evidence. A reaffirmation date is included in the online version of a document to indicate when it was last reviewed. The current status and any updates of this document can be found on ACOG Clinical at acog.org/lot.While ACOG makes every effort to present accurate and reliable information, this publication is provided "as is" without any warranty of accuracy, reliability, or otherwise, either express or implied. ACOG does not guarantee, warrant, or endorse the products or services of any firm, organization, or person. Neither ACOG nor its officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Instructional Material/Guideline-3 content type line 23 |
| PMID | 37590986 |
| PQID | 2853943163 |
| PQPubID | 23479 |
| PageCount | 15 |
| ParticipantIDs | proquest_miscellaneous_2853943163 pubmed_primary_37590986 crossref_primary_10_1097_AOG_0000000000005300 crossref_citationtrail_10_1097_AOG_0000000000005300 wolterskluwer_health_10_1097_AOG_0000000000005300 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-September 2023-09-00 2023-09-01 20230901 |
| PublicationDateYYYYMMDD | 2023-09-01 |
| PublicationDate_xml | – month: 09 year: 2023 text: 2023-September |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Obstetrics and gynecology (New York. 1953) |
| PublicationTitleAlternate | Obstet Gynecol |
| PublicationYear | 2023 |
| Publisher | Lippincott Williams & Wilkins |
| Publisher_xml | – name: Lippincott Williams & Wilkins |
| References | Eke, Eleje, Eke, Xia, Liu (R55) 2017 Glikson, Galun, Oren, Tur-Kaspa, Shouval (R8) 1992; 71 Prabhu, Susich, Packer, Hersch, Riley, Caughey (R28) 2022; 139 Fiore (R6) 2004; 38 Terrault, Bzowej, Chang, Hwang, Jonas, Murad (R46) 2016; 63 Deng, Zhou, Gao, Yang, Wang, Chen (R51) 2012; 9 Abdul Massih, Eke (R38) 2022; 20 R68 Chen, Zha, Cai, Qin (R48) 2018; 48 Conners, Panagiotakopoulos, Hofmeister, Spradling, Hagan, Harris (R27) 2023; 72 Staes, Schlenker, Risk, Cannon, Harris, Pavia (R7) 2000; 106 Kushner, Djerboua, Biondi, Feld, Terrault, Flemming (R40) 2022; 77 Abara, Qaseem, Schillie, McMahon, Harris, Abraham (R31) 2017; 167 Han, Jiang, Wang, Ding, Wang, Yue (R53) 2017; 24 Tran (R11) 2016; 62 R2 Huang, Hang, Zhong, Gao, Luo, Yu (R42) 2016; 95 Schillie, Walker, Veselsky, Crowley, Dusek, Lazaroff (R47) 2015; 135 McIntyre, Tosh, McGuire (R65) 2006; 2006 Chen, Chen, Wen, Xu, Zhang, Zhou (R62) 2013; 8 Jin, Zhao, Zhang, Wang, Liu (R21) 2016; 144 Dionne-Odom, Cozzi, Franco, Njei, Tita (R69) 2022; 226 Chang, Gavini, Andrade, McNabb-Baltar (R59) 2014; 28 Nguyen, Thavorncharoensap, Phung, Anothaisintawee, Chaikledkaew, Sobhonslidsuk (R54) 2022; 227 Lachish, Erez, Daudi, Shouval, Schwartz (R23) 2015; 73 Dotters-Katz, Kuller, Hughes (R36) 2021; 225 Centers for Disease Control and Prevention. Viral hepatitis surveillance report - United States, 2019. Accessed March 25, 2022. https://www.cdc.gov/hepatitis/statistics/2019surveillance/index.htm Han, Jiang, Yue, Ding, Wang, Wang (R52) 2015; 22 R37 Owens, Davidson, Krist, Barry, Cabana, Caughey (R35) 2020; 323 Yi, Pan, Hao, Hu, Liu, Li (R56) 2014; 60 Nelson, Weng, Hofmeister, Moore, Doshani, Kamili (R71) 2020; 69 Drobeniuc, Hutin, Harpaz, Favorov, Melnik, Iarovoi (R19) 1999; 123 (R57) 2016; 127 Elinav, Ben-Dov, Shapira, Daudi, Adler, Shouval (R9) 2006; 130 Aggarwal, Krawczynski (R20) 2000; 15 Owens, Davidson, Krist, Barry, Cabana, Caughey (R26) 2019; 322 Weng, Doshani, Khan, Frey, Ault, Moore (R30) 2022; 71 Ehrhardt, Xie, Guo, Nelson, Thio (R63) 2015; 60 Guyatt, Schünemann, Djulbegovic, Akl (R5) 2015; 68 Dionne-Odom, Tita, Silverman (R32) 2016; 214 Zheng, Lu, Ye, Xia, Zhou, Yao (R60) 2011; 11 Cottrell, Chou, Wasson, Rahman, Guise (R64) 2013; 158 Pérez-Gracia, Suay-García, Mateos-Lindemann (R22) 2017; 27 Bleich, Swenson (R44) 2014; 48 Shi, Yang, Wang, Ma, Schreiber, Li (R61) 2011; 165 Guyatt, Oxman, Akl, Kunz, Vist, Brozek (R4) 2011; 64 Kolasa, Tsai, Xu, Fenlon, Schillie (R33) 2017; 36 Ghamar Chehreh, Tabatabaei, Khazanehdari, Alavian (R66) 2011; 283 Coffin, Fung, Alvarez, Cooper, Doucette, Fournier (R50) 2018; 1 (R1) 2021; 138 Castillo, Murphy, van Schalkwyk (R49) 2017; 39 Yang, Zeng, Men, Zhao (R58) 2008; 5 Schillie, Wester, Osborne, Wesolowski, Ryerson (R13) 2020; 69 Curtis, Chappell (R39) 2023; 20 Toy, Hutton, Harris, Nelson, Salomon, So (R29) 2022; 74 Pembrey, Newell, Tovo (R67) 2005; 43 Schillie, Vellozzi, Reingold, Harris, Haber, Ward (R12) 2018; 67 Sharma, Kumar, Kar, Agarwal, Ramji, Husain (R24) 2017; 24 Workowski, Bachmann, Chan, Johnston, Muzny, Park (R25) 2021; 70 Guyatt, Oxman, Vist, Kunz, Falck-Ytter, Alonso-Coello (R3) 2008; 336 Patrick, Dupont, McNeer, McPheeters, Cooper, Aronoff (R16) 2021; 2 Hoofnagle (R18) 1989; 261 Huang, Huang, Zhong, Wei, Luo, Li (R41) 2015; 22 Fagan, Hadzic, Saxena, Mieli-Vergani (R10) 1999; 18 Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH. Red book: 2021-2024 report of the Committee on Infectious Diseases. 32nd ed. Accessed April 5, 2022. https://publications.aap.org/redbook/book/347/Red-Book-2021-2024-Report-of-the-Committee-on Moorman, de Perio, Goldschmidt, Chu, Kuhar, Henderson (R70) 2020; 69 Wijarnpreecha, Thongprayoon, Sanguankeo, Upala, Ungprasert, Cheungpasitporn (R43) 2017; 41 Jeffers, Hasan, De Medina, Reddy, Parker, Silva (R17) 1992; 15 Nguyen, Tan, Greenup, Glass, Davison, Samarasinghe (R45) 2014; 39 Centers for Disease Control and Prevention. 2020 viral hepatitis surveillance report. Accessed June 14, 2023. https://www.cdc.gov/hepatitis/statistics/2020surveillance/index.htm Abdul Massih (R38-20250502) 2022; 20 Guyatt (R4-20250502) 2011; 64 Huang (R41-20250502) 2015; 22 Moorman (R70-20250502) 2020; 69 Workowski (R25-20250502) 2021; 70 Ehrhardt (R63-20250502) 2015; 60 Pembrey (R67-20250502) 2005; 43 Coffin (R50-20250502) 2018; 1 Fagan (R10-20250502) 1999; 18 (R57-20250502) 2016; 127 Lachish (R23-20250502) 2015; 73 Castillo (R49-20250502) 2017; 39 Chen (R48-20250502) 2018; 48 Eke (R55-20250502) 2017 Kolasa (R33-20250502) 2017; 36 Guyatt (R5-20250502) 2015; 68 Huang (R42-20250502) 2016; 95 McIntyre (R65-20250502) 2006; 2006 Nelson (R71-20250502) 2020; 69 Deng (R51-20250502) 2012; 9 Weng (R30-20250502) 2022; 71 Dionne-Odom (R32-20250502) 2016; 214 Yi (R56-20250502) 2014; 60 Han (R53-20250502) 2017; 24 Chang (R59-20250502) 2014; 28 Kushner (R40-20250502) 2022; 77 Abara (R31-20250502) 2017; 167 Chen (R62-20250502) 2013; 8 Pérez-Gracia (R22-20250502) 2017; 27 Conners (R27-20250502) 2023; 72 Owens (R35-20250502) 2020; 323 Schillie (R12-20250502) 2018; 67 Nguyen (R54-20250502) 2022; 227 Dionne-Odom (R69-20250502) 2022; 226 Dotters-Katz (R36-20250502) 2021; 225 Schillie (R13-20250502) 2020; 69 Aggarwal (R20-20250502) 2000; 15 Sharma (R24-20250502) 2017; 24 Han (R52-20250502) 2015; 22 Hoofnagle (R18-20250502) 1989; 261 Wijarnpreecha (R43-20250502) 2017; 41 Prabhu (R28-20250502) 2022; 139 Toy (R29-20250502) 2022; 74 Bleich (R44-20250502) 2014; 48 Staes (R7-20250502) 2000; 106 Ghamar Chehreh (R66-20250502) 2011; 283 Curtis (R39-20250502) 2023; 20 Cottrell (R64-20250502) 2013; 158 Guyatt (R3-20250502) 2008; 336 Zheng (R60-20250502) 2011; 11 (R1-20250502) 2021; 138 Elinav (R9-20250502) 2006; 130 Patrick (R16-20250502) 2021; 2 Schillie (R47-20250502) 2015; 135 Yang (R58-20250502) 2008; 5 Tran (R11-20250502) 2016; 62 Jeffers (R17-20250502) 1992; 15 Drobeniuc (R19-20250502) 1999; 123 Terrault (R46-20250502) 2016; 63 Fiore (R6-20250502) 2004; 38 Nguyen (R45-20250502) 2014; 39 Shi (R61-20250502) 2011; 165 Glikson (R8-20250502) 1992; 71 Jin (R21-20250502) 2016; 144 Owens (R26-20250502) 2019; 322 38716205 - Transl Gastroenterol Hepatol. 2024 Apr 16;9:31 |
| References_xml | – volume: 214 start-page: 6 year: 2016 end-page: 14 ident: R32 article-title: #38: hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2015.09.100 – volume: 22 start-page: 1033 year: 2015 end-page: 42 ident: R41 article-title: Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta-analysis of observational studies publication-title: J Viral Hepat doi: 10.1111/jvh.12430 – volume: 15 start-page: 187 year: 1992 end-page: 90 ident: R17 article-title: Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis publication-title: Hepatology doi: 10.1002/hep.1840150204 – volume: 11 start-page: 502 year: 2011 ident: R60 article-title: Should chronic hepatitis B mothers breastfeed? A meta analysis publication-title: BMC Public Health doi: 10.1186/1471-2458-11-502 – volume: 70 start-page: 1 year: 2021 end-page: 187 ident: R25 article-title: Sexually transmitted infections treatment guidelines, 2021 publication-title: MMWR Recomm Rep doi: 10.15585/mmwr.rr7004a1 – volume: 62 start-page: S314 year: 2016 end-page: 7 ident: R11 article-title: Hepatitis B in pregnancy publication-title: Clin Infect Dis doi: 10.1093/cid/ciw092 – volume: 69 start-page: 1 year: 2020 end-page: 17 ident: R13 article-title: CDC recommendations for hepatitis C screening among adults - United States, 2020 publication-title: MMWR Recomm Rep doi: 10.15585/mmwr.rr6902a1 – volume: 138 start-page: 518 year: 2021 end-page: 22 ident: R1 article-title: Clinical practice guideline methodology: methodology publication-title: Obstet Gynecol doi: 10.1097/AOG.0000000000004519 – volume: 2006 start-page: CD005546 year: 2006 ident: R65 article-title: Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission publication-title: The Cochrane Database of Systematic Reviews doi: 10.1002/14651858.CD005546.pub2 – volume: 43 start-page: 515 year: 2005 end-page: 25 ident: R67 article-title: The management of HCV infected pregnant women and their children European paediatric HCV network publication-title: J Hepatol doi: 10.1016/j.jhep.2005.06.002 – volume: 24 start-page: 514 year: 2017 end-page: 21 ident: R53 article-title: Long-term safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy publication-title: J Viral Hepat doi: 10.1111/jvh.12670 – volume: 28 start-page: 439 year: 2014 end-page: 44 ident: R59 article-title: Caesarean section to prevent transmission of hepatitis B: a meta-analysis publication-title: Can J Gastroenterol Hepatol doi: 10.1155/2014/350179 – volume: 18 start-page: 389 year: 1999 end-page: 91 ident: R10 article-title: Symptomatic neonatal hepatitis A disease from a virus variant acquired in utero publication-title: Pediatr Infect Dis J doi: 10.1097/00006454-199904000-00020 – volume: 323 start-page: 970 year: 2020 end-page: 5 ident: R35 article-title: Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force recommendation statement. US Preventive Services Task Force publication-title: JAMA doi: 10.1001/jama.2020.1123 – volume: 9 start-page: 185 year: 2012 ident: R51 article-title: The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis publication-title: Virol J doi: 10.1186/1743-422X-9-185 – volume: 5 start-page: 100 year: 2008 ident: R58 article-title: Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus-a systematic review publication-title: Virol J doi: 10.1186/1743-422X-5-100 – volume: 336 start-page: 924 year: 2008 end-page: 6 ident: R3 article-title: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations publication-title: BMJ doi: 10.1136/bmj.39489.470347 – volume: 322 start-page: 349 year: 2019 end-page: 54 ident: R26 article-title: Screening for hepatitis B virus infection in pregnant women: US Preventive Services Task Force reaffirmation recommendation statement. US Preventive Services Task Force [published erratum appears in JAMA 2019;322:1108] publication-title: JAMA doi: 10.1001/jama.2019.9365 – reference: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH. Red book: 2021-2024 report of the Committee on Infectious Diseases. 32nd ed. Accessed April 5, 2022. https://publications.aap.org/redbook/book/347/Red-Book-2021-2024-Report-of-the-Committee-on – volume: 20 start-page: 1 year: 2023 end-page: 8 ident: R39 article-title: Evidence for implementation: HIV/HCV coinfection and pregnancy publication-title: Curr HIV/AIDS Rep doi: 10.1007/s11904-022-00643-9 – volume: 20 start-page: 1413 year: 2022 end-page: 24 ident: R38 article-title: Direct antiviral agents (DAAs) and their use in pregnant women with hepatitis C (HCV) publication-title: Expert Rev Anti-infective Ther doi: 10.1080/14787210.2022.2125868 – volume: 48 start-page: 788 year: 2018 end-page: 801 ident: R48 article-title: Maternal viral load and hepatitis B virus mother-to-child transmission risk: a systematic review and meta-analysis publication-title: Hepatol Res doi: 10.1111/hepr.13072 – volume: 64 start-page: 383 year: 2011 end-page: 94 ident: R4 article-title: GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2010.04.026 – volume: 227 start-page: 163 year: 2022 end-page: 72 ident: R54 article-title: Comparative efficacy and safety of pharmacologic interventions to prevent mother-to-child transmission of hepatitis B virus: a systematic review and network meta-analysis publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2022.02.042 – volume: 130 start-page: 1129 year: 2006 end-page: 34 ident: R9 article-title: Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor publication-title: Gastroenterology doi: 10.1053/j.gastro.2006.01.007 – ident: R68 article-title: . Hepatitis A questions and answers for health professionals – volume: 144 start-page: 2098 year: 2016 end-page: 106 ident: R21 article-title: Case-fatality risk of pregnant women with acute viral hepatitis type E: a systematic review and meta-analysis publication-title: Epidemiol Infect doi: 10.1017/S0950268816000418 – ident: R2 article-title: Human development reports. Human Development Index (HDI) – volume: 39 start-page: 1225 year: 2014 end-page: 34 ident: R45 article-title: Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.12726 – volume: 63 start-page: 261 year: 2016 end-page: 83 ident: R46 article-title: AASLD guidelines for treatment of chronic hepatitis B publication-title: Hepatology doi: 10.1002/hep.28156 – volume: 69 start-page: 1 year: 2020 end-page: 38 ident: R71 article-title: Prevention of hepatitis A virus infection in the United States: recommendations of the advisory committee on immunization practices, 2020 MMW publication-title: MMWR Recomm Rep doi: 10.15585/mmwr.rr6905a1 – volume: 68 start-page: 597 year: 2015 end-page: 600 ident: R5 article-title: Guideline panels should not GRADE good practice statements publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2014.12.011 – volume: 41 start-page: 39 year: 2017 end-page: 45 ident: R43 article-title: Hepatitis C infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis publication-title: Clin Res Hepatol Gastroenterol doi: 10.1016/j.clinre.2016.07.004 – volume: 127 start-page: e108 year: 2016 end-page: 22 ident: R57 article-title: Prenatal diagnostic testing for genetic disorders. Practice Bulletin No. 162. American College of Obstetricians and Gynecologists publication-title: Obstet Gynecol doi: 10.1097/AOG.0000000000001405 – volume: 139 start-page: 357 year: 2022 end-page: 67 ident: R28 article-title: Universal hepatitis B antibody screening and vaccination in pregnancy: a cost-effectiveness analysis [published erratum appears in Obstet Gynecol 2022;139:696] publication-title: Obstet Gynecol doi: 10.1097/AOG.0000000000004652 – volume: 48 start-page: 765 year: 2014 end-page: 72 ident: R44 article-title: Prevention of neonatal hepatitis B virus transmission publication-title: J Clin Gastroenterol doi: 10.1097/MCG.0000000000000115 – volume: 2 start-page: e213470 year: 2021 ident: R16 article-title: Association of individual and community factors with hepatitis C infections among pregnant people and newborns [published erratum appears in JAMA Health Forum 2021;2:e214347] publication-title: JAMA Health Forum doi: 10.1001/jamahealthforum.2021.3470 – volume: 165 start-page: 837 year: 2011 end-page: 46 ident: R61 article-title: Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review publication-title: Arch Pediatr Adolesc Med doi: 10.1001/archpediatrics.2011.72 – reference: Centers for Disease Control and Prevention. 2020 viral hepatitis surveillance report. Accessed June 14, 2023. https://www.cdc.gov/hepatitis/statistics/2020surveillance/index.htm – volume: 225 start-page: B8 year: 2021 end-page: 18 ident: R36 article-title: Society for maternal-fetal medicine consult series #56: hepatitis C in pregnancy-updated guidelines publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2021.06.008 – volume: 36 start-page: e175 year: 2017 end-page: 80 ident: R33 article-title: Hepatitis B surface antigen testing among pregnant women, United States 2014 publication-title: Pediatr Infect Dis J doi: 10.1097/INF.0000000000001516 – ident: R37 article-title: HCV guidance: recommendations for testing, managing, and treating hepatitis C – volume: 67 start-page: 1 year: 2018 end-page: 31 ident: R12 article-title: Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices publication-title: MMWR Recomm Rep doi: 10.15585/mmwr.rr6701a1 – volume: 8 start-page: e55303 year: 2013 ident: R62 article-title: Breastfeeding is not a risk factor for mother-to-child transmission of hepatitis B virus publication-title: PLoS One doi: 10.1371/journal.pone.0055303 – volume: 95 start-page: e4777 issue: 35 year: 2016 ident: R42 article-title: Maternal HCV infection is associated with intrauterine fetal growth disturbance: a meta-analysis of observational studies [published erratum appears in Medicine (Baltimore) 2016;95:e266c] doi: 10.1097/MD.0000000000004777 – volume: 283 start-page: 255 year: 2011 end-page: 60 ident: R66 article-title: Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIV- mothers: a meta-analysis publication-title: Arch Gynecol Obstet doi: 10.1007/s00404-010-1588-9 – volume: 261 start-page: 1321 year: 1989 end-page: 5 ident: R18 article-title: Type D (delta) hepatitis publication-title: JAMA: J Am Med Assoc doi: 10.1001/jama.261.9.1321 – reference: Centers for Disease Control and Prevention. Viral hepatitis surveillance report - United States, 2019. Accessed March 25, 2022. https://www.cdc.gov/hepatitis/statistics/2019surveillance/index.htm – volume: 22 start-page: 754 year: 2015 end-page: 62 ident: R52 article-title: Efficacy and safety of telbivudine treatment: an open-label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection publication-title: J Viral Hepat doi: 10.1111/jvh.12379 – year: 2017 ident: R55 article-title: Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus publication-title: The Cochrane Database of Systematic Reviews doi: 10.1002/14651858.CD008545.pub2 – volume: 38 start-page: 705 year: 2004 end-page: 15 ident: R6 article-title: Hepatitis A transmitted by food publication-title: Clin Infect Dis doi: 10.1086/381671 – volume: 72 start-page: 1 year: 2023 end-page: 25 ident: R27 article-title: Screening and testing for hepatitis B virus infection: CDC recommendations - United States, 2023 publication-title: MMWR Recomm Rep doi: 10.15585/mmwr.rr7201a1 – volume: 69 start-page: 1 year: 2020 end-page: 8 ident: R70 article-title: Testing and clinical management of health care personnel potentially exposed to hepatitis C virus - CDC guidance, United States, 2020 publication-title: MMWR Recomm Rep doi: 10.15585/mmwr.rr6906a1 – volume: 71 start-page: 14 year: 1992 end-page: 23 ident: R8 article-title: Relapsing hepatitis A. Review of 14 cases and literature survey publication-title: Medicine (Baltimore) doi: 10.1097/00005792-199201000-00002 – volume: 60 start-page: 275 year: 2015 end-page: 8 ident: R63 article-title: Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence publication-title: Clin Infect Dis doi: 10.1093/cid/ciu798 – volume: 167 start-page: 794 year: 2017 end-page: 804 ident: R31 article-title: Hepatitis B vaccination, screening, and linkage to care: best practice advice from the American College of physicians and the Centers for Disease Control and Prevention publication-title: Ann Intern Med doi: 10.7326/M17-1106 – volume: 1 start-page: 156 year: 2018 end-page: 217 ident: R50 article-title: Management of hepatitis B virus infection: 2018 guidelines from the Canadian association for the study of liver disease and association of medical microbiology and infectious disease Canada publication-title: Can Liver J doi: 10.3138/canlivj.2018-0008 – volume: 24 start-page: 1067 year: 2017 end-page: 75 ident: R24 article-title: Risk factors for vertical transmission of hepatitis E virus infection publication-title: J Viral Hepat doi: 10.1111/jvh.12730 – volume: 15 start-page: 9 year: 2000 end-page: 20 ident: R20 article-title: Hepatitis E: an overview and recent advances in clinical and laboratory research publication-title: J Gastroenterol Hepatol doi: 10.1046/j.1440-1746.2000.02006.x – volume: 77 start-page: 1256 year: 2022 end-page: 64 ident: R40 article-title: Influence of hepatitis C viral parameters on pregnancy complications and risk of mother-to-child transmission publication-title: J Hepatol doi: 10.1016/j.jhep.2022.05.016 – volume: 39 start-page: 181 year: 2017 end-page: 90 ident: R49 article-title: No. 342-hepatitis B and pregnancy publication-title: J Obstet Gynaecol Can doi: 10.1016/j.jogc.2016.11.001 – volume: 27 start-page: e1929 year: 2017 ident: R22 article-title: Hepatitis E and pregnancy: current state publication-title: Rev Med Virol doi: 10.1002/rmv.1929 – volume: 106 start-page: E54 year: 2000 ident: R7 article-title: Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak publication-title: Pediatrics doi: 10.1542/peds.106.4.e54 – volume: 60 start-page: 523 year: 2014 end-page: 9 ident: R56 article-title: Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers publication-title: J Hepatol doi: 10.1016/j.jhep.2013.11.008 – volume: 73 start-page: 20 year: 2015 end-page: 4 ident: R23 article-title: Acute hepatitis E virus in pregnant women in Israel and in other industrialized countries publication-title: J Clin Virol doi: 10.1016/j.jcv.2015.10.011 – volume: 123 start-page: 463 year: 1999 end-page: 7 ident: R19 article-title: Prevalence of hepatitis B, D and C virus infections among children and pregnant women in Moldova: additional evidence supporting the need for routine hepatitis B vaccination of infants publication-title: Epidemiol Infect doi: 10.1017/s0950268899003003 – volume: 158 start-page: 109 year: 2013 end-page: 13 ident: R64 article-title: Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force publication-title: Ann Intern Med doi: 10.7326/0003-4819-158-2-201301150-00575 – volume: 74 start-page: 210 year: 2022 end-page: 7 ident: R29 article-title: Cost-effectiveness of 1-time universal screening for chronic hepatitis B infection in adults in the United States publication-title: Clin Infect Dis doi: 10.1093/cid/ciab405 – volume: 135 start-page: e1141 year: 2015 end-page: 7 ident: R47 article-title: Outcomes of infants born to women infected with hepatitis B publication-title: Pediatrics doi: 10.1542/peds.2014-3213 – volume: 226 start-page: 335 year: 2022 end-page: 46 ident: R69 article-title: Treatment and prevention of viral hepatitis in pregnancy publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2021.09.002 – volume: 71 start-page: 477 year: 2022 end-page: 83 ident: R30 article-title: Universal hepatitis B vaccination in adults aged 19-59 Years: updated recommendations of the advisory committee on immunization practices - United States, 2022 publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm7113a1 – volume: 69 start-page: 1 year: 2020 ident: R13-20250502 article-title: CDC recommendations for hepatitis C screening among adults - United States, 2020 publication-title: MMWR Recomm Rep doi: 10.15585/mmwr.rr6902a1 – volume: 2006 start-page: CD005546 year: 2006 ident: R65-20250502 article-title: Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission publication-title: The Cochrane Database of Systematic Reviews – volume: 106 start-page: E54 year: 2000 ident: R7-20250502 article-title: Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak publication-title: Pediatrics doi: 10.1542/peds.106.4.e54 – volume: 138 start-page: 518 year: 2021 ident: R1-20250502 article-title: Clinical practice guideline methodology: methodology publication-title: Obstet Gynecol doi: 10.1097/AOG.0000000000004519 – volume: 336 start-page: 924 year: 2008 ident: R3-20250502 article-title: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations publication-title: BMJ doi: 10.1136/bmj.39489.470347.AD – volume: 27 start-page: e1929 year: 2017 ident: R22-20250502 article-title: Hepatitis E and pregnancy: current state publication-title: Rev Med Virol doi: 10.1002/rmv.1929 – volume: 225 start-page: B8 year: 2021 ident: R36-20250502 article-title: Society for maternal-fetal medicine consult series #56: hepatitis C in pregnancy—updated guidelines publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2021.06.008 – volume: 5 start-page: 100 year: 2008 ident: R58-20250502 article-title: Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus—a systematic review publication-title: Virol J doi: 10.1186/1743-422X-5-100 – volume: 20 start-page: 1413 year: 2022 ident: R38-20250502 article-title: Direct antiviral agents (DAAs) and their use in pregnant women with hepatitis C (HCV) publication-title: Expert Rev Anti-infective Ther doi: 10.1080/14787210.2022.2125868 – volume: 39 start-page: 1225 year: 2014 ident: R45-20250502 article-title: Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.12726 – volume: 144 start-page: 2098 year: 2016 ident: R21-20250502 article-title: Case-fatality risk of pregnant women with acute viral hepatitis type E: a systematic review and meta-analysis publication-title: Epidemiol Infect doi: 10.1017/S0950268816000418 – volume: 69 start-page: 1 year: 2020 ident: R70-20250502 article-title: Testing and clinical management of health care personnel potentially exposed to hepatitis C virus — CDC guidance, United States, 2020 publication-title: MMWR Recomm Rep doi: 10.15585/mmwr.rr6906a1 – volume: 36 start-page: e175 year: 2017 ident: R33-20250502 article-title: Hepatitis B surface antigen testing among pregnant women, United States 2014 publication-title: Pediatr Infect Dis J doi: 10.1097/INF.0000000000001516 – volume: 60 start-page: 523 year: 2014 ident: R56-20250502 article-title: Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers publication-title: J Hepatol doi: 10.1016/j.jhep.2013.11.008 – volume: 72 start-page: 1 year: 2023 ident: R27-20250502 article-title: Screening and testing for hepatitis B virus infection: CDC recommendations — United States, 2023 publication-title: MMWR Recomm Rep doi: 10.15585/mmwr.rr7201a1 – volume: 323 start-page: 970 year: 2020 ident: R35-20250502 article-title: Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force recommendation statement. US Preventive Services Task Force publication-title: JAMA doi: 10.1001/jama.2020.1123 – volume: 226 start-page: 335 year: 2022 ident: R69-20250502 article-title: Treatment and prevention of viral hepatitis in pregnancy publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2021.09.002 – volume: 139 start-page: 357 year: 2022 ident: R28-20250502 article-title: Universal hepatitis B antibody screening and vaccination in pregnancy: a cost-effectiveness analysis [published erratum appears in Obstet Gynecol 2022;139:696] publication-title: Obstet Gynecol doi: 10.1097/AOG.0000000000004652 – volume: 1 start-page: 156 year: 2018 ident: R50-20250502 article-title: Management of hepatitis B virus infection: 2018 guidelines from the Canadian association for the study of liver disease and association of medical microbiology and infectious disease Canada publication-title: Can Liver J doi: 10.3138/canlivj.2018-0008 – volume: 20 start-page: 1 year: 2023 ident: R39-20250502 article-title: Evidence for implementation: HIV/HCV coinfection and pregnancy publication-title: Curr HIV/AIDS Rep doi: 10.1007/s11904-022-00643-9 – volume: 63 start-page: 261 year: 2016 ident: R46-20250502 article-title: AASLD guidelines for treatment of chronic hepatitis B publication-title: Hepatology doi: 10.1002/hep.28156 – volume: 227 start-page: 163 year: 2022 ident: R54-20250502 article-title: Comparative efficacy and safety of pharmacologic interventions to prevent mother-to-child transmission of hepatitis B virus: a systematic review and network meta-analysis publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2022.02.042 – volume: 167 start-page: 794 year: 2017 ident: R31-20250502 article-title: Hepatitis B vaccination, screening, and linkage to care: best practice advice from the American College of physicians and the Centers for Disease Control and Prevention publication-title: Ann Intern Med doi: 10.7326/M17-1106 – volume: 158 start-page: 109 year: 2013 ident: R64-20250502 article-title: Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force publication-title: Ann Intern Med doi: 10.7326/0003-4819-158-2-201301150-00575 – volume: 38 start-page: 705 year: 2004 ident: R6-20250502 article-title: Hepatitis A transmitted by food publication-title: Clin Infect Dis doi: 10.1086/381671 – volume: 41 start-page: 39 year: 2017 ident: R43-20250502 article-title: Hepatitis C infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis publication-title: Clin Res Hepatol Gastroenterol doi: 10.1016/j.clinre.2016.07.004 – volume: 77 start-page: 1256 year: 2022 ident: R40-20250502 article-title: Influence of hepatitis C viral parameters on pregnancy complications and risk of mother-to-child transmission publication-title: J Hepatol doi: 10.1016/j.jhep.2022.05.016 – volume: 22 start-page: 1033 year: 2015 ident: R41-20250502 article-title: Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta-analysis of observational studies publication-title: J Viral Hepat doi: 10.1111/jvh.12430 – volume: 69 start-page: 1 year: 2020 ident: R71-20250502 article-title: Prevention of hepatitis A virus infection in the United States: recommendations of the advisory committee on immunization practices, 2020 MMW publication-title: MMWR Recomm Rep doi: 10.15585/mmwr.rr6905a1 – volume: 11 start-page: 502 year: 2011 ident: R60-20250502 article-title: Should chronic hepatitis B mothers breastfeed? A meta analysis publication-title: BMC Public Health doi: 10.1186/1471-2458-11-502 – volume: 123 start-page: 463 year: 1999 ident: R19-20250502 article-title: Prevalence of hepatitis B, D and C virus infections among children and pregnant women in Moldova: additional evidence supporting the need for routine hepatitis B vaccination of infants publication-title: Epidemiol Infect doi: 10.1017/S0950268899003003 – volume: 60 start-page: 275 year: 2015 ident: R63-20250502 article-title: Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence publication-title: Clin Infect Dis doi: 10.1093/cid/ciu798 – volume: 15 start-page: 187 year: 1992 ident: R17-20250502 article-title: Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis publication-title: Hepatology doi: 10.1002/hep.1840150204 – volume: 48 start-page: 765 year: 2014 ident: R44-20250502 article-title: Prevention of neonatal hepatitis B virus transmission publication-title: J Clin Gastroenterol doi: 10.1097/MCG.0000000000000115 – volume: 165 start-page: 837 year: 2011 ident: R61-20250502 article-title: Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review publication-title: Arch Pediatr Adolesc Med doi: 10.1001/archpediatrics.2011.72 – volume: 283 start-page: 255 year: 2011 ident: R66-20250502 article-title: Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIV- mothers: a meta-analysis publication-title: Arch Gynecol Obstet doi: 10.1007/s00404-010-1588-9 – volume: 70 start-page: 1 year: 2021 ident: R25-20250502 article-title: Sexually transmitted infections treatment guidelines, 2021 publication-title: MMWR Recomm Rep doi: 10.15585/mmwr.rr7004a1 – volume: 95 start-page: e4777 issue: 35 year: 2016 ident: R42-20250502 article-title: Maternal HCV infection is associated with intrauterine fetal growth disturbance: a meta-analysis of observational studies [published erratum appears in Medicine (Baltimore) 2016;95:e266c] – volume: 39 start-page: 181 year: 2017 ident: R49-20250502 article-title: No. 342-hepatitis B and pregnancy publication-title: J Obstet Gynaecol Can doi: 10.1016/j.jogc.2016.11.001 – year: 2017 ident: R55-20250502 article-title: Hepatitis B immunoglobulin during pregnancy for prevention of mother‐to‐child transmission of hepatitis B virus publication-title: The Cochrane Database of Systematic Reviews doi: 10.1002/14651858.CD008545.pub2 – volume: 15 start-page: 9 year: 2000 ident: R20-20250502 article-title: Hepatitis E: an overview and recent advances in clinical and laboratory research publication-title: J Gastroenterol Hepatol doi: 10.1046/j.1440-1746.2000.02006.x – volume: 130 start-page: 1129 year: 2006 ident: R9-20250502 article-title: Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor publication-title: Gastroenterology doi: 10.1053/j.gastro.2006.01.007 – volume: 2 start-page: e213470 year: 2021 ident: R16-20250502 article-title: Association of individual and community factors with hepatitis C infections among pregnant people and newborns [published erratum appears in JAMA Health Forum 2021;2:e214347] publication-title: JAMA Health Forum doi: 10.1001/jamahealthforum.2021.3470 – volume: 73 start-page: 20 year: 2015 ident: R23-20250502 article-title: Acute hepatitis E virus in pregnant women in Israel and in other industrialized countries publication-title: J Clin Virol doi: 10.1016/j.jcv.2015.10.011 – volume: 9 start-page: 185 year: 2012 ident: R51-20250502 article-title: The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis publication-title: Virol J doi: 10.1186/1743-422X-9-185 – volume: 74 start-page: 210 year: 2022 ident: R29-20250502 article-title: Cost-effectiveness of 1-time universal screening for chronic hepatitis B infection in adults in the United States publication-title: Clin Infect Dis doi: 10.1093/cid/ciab405 – volume: 214 start-page: 6 year: 2016 ident: R32-20250502 article-title: #38: hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2015.09.100 – volume: 28 start-page: 439 year: 2014 ident: R59-20250502 article-title: Caesarean section to prevent transmission of hepatitis B: a meta-analysis publication-title: Can J Gastroenterol Hepatol doi: 10.1155/2014/350179 – volume: 135 start-page: e1141 year: 2015 ident: R47-20250502 article-title: Outcomes of infants born to women infected with hepatitis B publication-title: Pediatrics doi: 10.1542/peds.2014-3213 – volume: 64 start-page: 383 year: 2011 ident: R4-20250502 article-title: GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2010.04.026 – volume: 48 start-page: 788 year: 2018 ident: R48-20250502 article-title: Maternal viral load and hepatitis B virus mother-to-child transmission risk: a systematic review and meta-analysis publication-title: Hepatol Res doi: 10.1111/hepr.13072 – volume: 24 start-page: 1067 year: 2017 ident: R24-20250502 article-title: Risk factors for vertical transmission of hepatitis E virus infection publication-title: J Viral Hepat doi: 10.1111/jvh.12730 – volume: 127 start-page: e108 year: 2016 ident: R57-20250502 article-title: Prenatal diagnostic testing for genetic disorders. Practice Bulletin No. 162. American College of Obstetricians and Gynecologists publication-title: Obstet Gynecol doi: 10.1097/AOG.0000000000001405 – volume: 18 start-page: 389 year: 1999 ident: R10-20250502 article-title: Symptomatic neonatal hepatitis A disease from a virus variant acquired in utero publication-title: Pediatr Infect Dis J doi: 10.1097/00006454-199904000-00020 – volume: 68 start-page: 597 year: 2015 ident: R5-20250502 article-title: Guideline panels should not GRADE good practice statements publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2014.12.011 – volume: 22 start-page: 754 year: 2015 ident: R52-20250502 article-title: Efficacy and safety of telbivudine treatment: an open-label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection publication-title: J Viral Hepat doi: 10.1111/jvh.12379 – volume: 24 start-page: 514 year: 2017 ident: R53-20250502 article-title: Long-term safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy publication-title: J Viral Hepat doi: 10.1111/jvh.12670 – volume: 8 start-page: e55303 year: 2013 ident: R62-20250502 article-title: Breastfeeding is not a risk factor for mother-to-child transmission of hepatitis B virus publication-title: PLoS One doi: 10.1371/journal.pone.0055303 – volume: 261 start-page: 1321 year: 1989 ident: R18-20250502 article-title: Type D (delta) hepatitis publication-title: JAMA: J Am Med Assoc doi: 10.1001/jama.1989.03420090085036 – volume: 71 start-page: 14 year: 1992 ident: R8-20250502 article-title: Relapsing hepatitis A. Review of 14 cases and literature survey publication-title: Medicine (Baltimore) doi: 10.1097/00005792-199201000-00002 – volume: 62 start-page: S314 year: 2016 ident: R11-20250502 article-title: Hepatitis B in pregnancy publication-title: Clin Infect Dis doi: 10.1093/cid/ciw092 – volume: 322 start-page: 349 year: 2019 ident: R26-20250502 article-title: Screening for hepatitis B virus infection in pregnant women: US Preventive Services Task Force reaffirmation recommendation statement. US Preventive Services Task Force [published erratum appears in JAMA 2019;322:1108] publication-title: JAMA – volume: 71 start-page: 477 year: 2022 ident: R30-20250502 article-title: Universal hepatitis B vaccination in adults aged 19–59 Years: updated recommendations of the advisory committee on immunization practices — United States, 2022 publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm7113a1 – volume: 43 start-page: 515 year: 2005 ident: R67-20250502 article-title: The management of HCV infected pregnant women and their children European paediatric HCV network publication-title: J Hepatol doi: 10.1016/j.jhep.2005.06.002 – volume: 67 start-page: 1 year: 2018 ident: R12-20250502 article-title: Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices publication-title: MMWR Recomm Rep doi: 10.15585/mmwr.rr6701a1 – reference: 38716205 - Transl Gastroenterol Hepatol. 2024 Apr 16;9:31 |
| SSID | ssj0001693 |
| Score | 2.5398088 |
| Snippet | PURPOSE:The purpose of this document is to describe the specific types of viral hepatitis, their implications during pregnancy, the risk of perinatal... The purpose of this document is to describe the specific types of viral hepatitis, their implications during pregnancy, the risk of perinatal transmission, and... |
| SourceID | proquest pubmed crossref wolterskluwer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 745 |
| SubjectTerms | Female Gynecology Hepacivirus Hepatitis B - diagnosis Hepatitis B - prevention & control Hepatitis C Humans Infectious Disease Transmission, Vertical - prevention & control Postpartum Period Pregnancy |
| Subtitle | ACOG Clinical Practice Guideline No. 6 |
| Title | Viral Hepatitis in Pregnancy |
| URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&DO=10.1097/AOG.0000000000005300 https://www.ncbi.nlm.nih.gov/pubmed/37590986 https://www.proquest.com/docview/2853943163 |
| Volume | 142 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1873-233X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001693 issn: 0029-7844 databaseCode: AKRWK dateStart: 19950101 isFulltext: true providerName: Library Specific Holdings |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3rb9MwED9BJyHQNPEalA0UJL4hDydO4vhjNdgGZe2ENti3KH5kqpjSqeuE4K_fOXbSlFU8lg9RlLfvl9ydz3c_A7wpDVpZpTKidSJJrMKCFBk1xOBba8XRYksbGjgcpQcn8afT5HQxN19dXTKXO-rXyrqS26CK-xBXWyX7H8i2N8UduI344hoRxvU_Yfx1Mqu5gW1W9HxSZ7YezcyZ5dBYGq0dS8TSUvE7Quazn5VRjnupMxfPzls71tVEBnwgIGJtppMPBKwgdKgDAZNzm23TVYKRIDxztIutEoyjDtqso9K4o3v01pE7_u4bitcR-g7G-44Q0i8Jo3RhaJrB9dE4P3q_l3_-OBouH6zN6ni0T7BxITqKd2Et4mka9WBtMPzybdiaWMsg0-Tu2JY0NZGCv1v1Css-x42OxANY_zG1uQmX3-vShI6DcfwQNnzPIBg4mB_BHVM9hnuHPvfhCWzXaAct2sGkClq0n8LJ3ofj3QPi57YgiqGTSTJtqAnDUqGO1WlmQkO50CVXkisdc0qNjMPSVgLLUAtlickyQaV1h7HDqijbhF41rcxzCEqqVcKLODEoCSFMYdDpjpOoiBQruOR9YE3rc-WJ3-38I-d5k4CAMst_l1kfSHvVhSM--cv5rxvB5qih7LBTUZnp1WUeoUcoLOMC68MzJ_H2jgy_JyqytA_hEgS5qwL-4xNf3OKaLbi_-HW2oTefXZmX6FXO5Sv_jV0DflZqiQ |
| linkProvider | Library Specific Holdings |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Viral+Hepatitis+in+Pregnancy&rft.jtitle=Obstetrics+and+gynecology+%28New+York.+1953%29&rft.date=2023-09-01&rft.pub=Lippincott+Williams+%26+Wilkins&rft.issn=0029-7844&rft.volume=142&rft.issue=3&rft.spage=745&rft.epage=759&rft_id=info:doi/10.1097%2FAOG.0000000000005300&rft.externalDBID=NO_PDF_LINK&rft.externalDocID=ONG-23-1163 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0029-7844&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0029-7844&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0029-7844&client=summon |